The Steering Committee is chosen by the EBF members from their midst and currently consists of the following 6 people:
- o Margarete Brudny-Kloeppel, Bayer, Germany
- o Peter van Amsterdam, Abbott Healthcare Products, Netherlands
- o Philip Timmerman, Janssen Research & Development, Belgium
- o Silke Luedtke, Boehringer Ingelheim, Germany
- o Michaela Golob, Merck-Serono, Germany
- o Arjen Companjen, Crucell, Netherlands
Last update: 06-Apr-2011
